A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC). uri icon

authors

  • Byun, Joo-Young
  • Park, Sun-Kyeong
  • Ng, Boon Peng
  • Liu, Yi-Shao
  • Kim, Chae-Rin
  • Chanhyun Park, PhD

publication date

  • January 1, 2022